Literature DB >> 11158421

Reversible Fanconi syndrome after ingestion of a Chinese herbal 'remedy' containing aristolochic acid.

B Krumme1, R Endmeir, M Vanhaelen, D Walb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158421     DOI: 10.1093/ndt/16.2.400

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

Review 1.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs.

Authors:  Yin-Tai Hong; Lin-Shien Fu; Lin-Huei Chung; Shien-Chung Hung; Yi-Ting Huang; Chin-Shiang Chi
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

Review 3.  An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Authors:  Inès Jadot; Anne-Emilie Declèves; Joëlle Nortier; Nathalie Caron
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

Review 4.  Environmental toxin-induced acute kidney injury.

Authors:  Benjamin A Vervaet; Patrick C D'Haese; Anja Verhulst
Journal:  Clin Kidney J       Date:  2017-07-28

Review 5.  Treatment of Lupus Nephritis from Iranian Traditional Medicine and Modern Medicine Points of View: A Comparative Study.

Authors:  Yasaman Vahedi-Mazdabadi; Mina Saeedi
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-09       Impact factor: 2.629

6.  Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003.

Authors:  Shu-Ching Hsieh; I-Hsin Lin; Wei-Lum Tseng; Chang-Hsing Lee; Jung-Der Wang
Journal:  Chin Med       Date:  2008-10-23       Impact factor: 5.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.